Windtree Therapeutics Stock Price, News & Analysis (OTCMKTS:WINT)

$0.24 -0.02 (-7.69 %)
(As of 12/13/2017 07:36 AM ET)
Previous Close$0.26
Today's Range$0.24 - $0.26
52-Week Range$0.18 - $1.85
Volume46,350 shs
Average Volume37,279 shs
Market Capitalization$16.44 million
P/E RatioN/A
Dividend YieldN/A
Beta1.76

About Windtree Therapeutics (OTCMKTS:WINT)

Windtree Therapeutics logoWindtree Therapeutics, Inc., formerly Discovery Laboratories, Inc., is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The Company operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment. The Company's technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant, and drug delivery technologies being developed to enable non-invasive administration of aerosolized KL4 surfactant. The Company's core development program, AEROSURF (lucinactant for inhalation), is focused on improving the management of respiratory distress syndrome (RDS) in premature infants, a respiratory condition that can result in long-term respiratory problems, developmental delay and death.

Receive WINT News and Ratings via Email

Sign-up to receive the latest news and ratings for WINT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryBiotechnology
SectorMedical
SymbolOTCMKTS:WINT
CUSIP25466840
Phone215-488-9300

Debt

Debt-to-Equity Ratio-0.33%
Current Ratio0.10%
Quick Ratio0.10%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.04 million
Price / Sales7.44
Cash FlowN/A
Price / CashN/A
Book Value($3.40) per share
Price / Book-0.07

Profitability

Trailing EPS($3.59)
Net Income$-39,490,000.00
Net Margins-1,205.47%
Return on EquityN/A
Return on Assets-345.52%

Miscellaneous

Employees49
Outstanding Shares63,210,000

Windtree Therapeutics (OTCMKTS:WINT) Frequently Asked Questions

What is Windtree Therapeutics' stock symbol?

Windtree Therapeutics trades on the OTCMKTS under the ticker symbol "WINT."

How were Windtree Therapeutics' earnings last quarter?

Windtree Therapeutics, Inc. (OTCMKTS:WINT) issued its quarterly earnings data on Monday, August, 21st. The biotechnology company reported ($0.76) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.99) by $0.23. The biotechnology company earned $1.15 million during the quarter, compared to analyst estimates of $0.40 million. View Windtree Therapeutics' Earnings History.

Who are some of Windtree Therapeutics' key competitors?

Who are Windtree Therapeutics' key executives?

Windtree Therapeutics' management team includes the folowing people:

  • John R. Leone, Independent Chairman of the Board (Age 68)
  • Craig Fraser, President, Chief Executive Officer, Director (Age 51)
  • John A. Tattory, Chief Financial Officer, Senior Vice President (Age 49)
  • Mary B. Templeton Esq., Senior Vice President, General Counsel and Corporate Secretary (Age 68)
  • Kathryn A. Cole, Senior Vice President - Human Resources (Age 49)
  • Steven G. Simonson M.D., Senior Vice President and Chief Development Officer (Age 56)
  • William C. Roberts, Vice President - Investor Relations and Corporate Communications (Age 45)
  • Michael L. Magee, Vice President - Technical Operations (Age 54)
  • Mahady M. Joseph, Independent Director (Age 63)
  • Bruce A. Peacock, Independent Director (Age 65)

How do I buy Windtree Therapeutics stock?

Shares of Windtree Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Windtree Therapeutics' stock price today?

One share of Windtree Therapeutics stock can currently be purchased for approximately $0.24.

How big of a company is Windtree Therapeutics?

Windtree Therapeutics has a market capitalization of $16.44 million and generates $2.04 million in revenue each year. The biotechnology company earns $-39,490,000.00 in net income (profit) each year or ($3.59) on an earnings per share basis. Windtree Therapeutics employs 49 workers across the globe.

How can I contact Windtree Therapeutics?

Windtree Therapeutics' mailing address is 2600 KELLY ROAD SUITE 100, WARRINGTON PA, 18976. The biotechnology company can be reached via phone at 215-488-9300 or via email at [email protected]


MarketBeat Community Rating for Windtree Therapeutics (WINT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  83 (Vote Outperform)
Underperform Votes:  69 (Vote Underperform)
Total Votes:  152
MarketBeat's community ratings are surveys of what our community members think about Windtree Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Windtree Therapeutics (OTCMKTS:WINT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.502.503.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $8.00$8.00$8.00$8.00
Price Target Upside: 841.18% upside841.18% upside841.18% upside290.24% upside

Windtree Therapeutics (OTCMKTS:WINT) Consensus Price Target History

Price Target History for Windtree Therapeutics (OTCMKTS:WINT)

Windtree Therapeutics (OTCMKTS:WINT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
6/30/2017Stifel NicolausDowngradeBuy -> HoldView Rating Details
10/30/2016HC WainwrightSet Price TargetBuy$8.00View Rating Details
(Data available from 12/13/2015 forward)

Earnings

Windtree Therapeutics (OTCMKTS:WINT) Earnings History and Estimates Chart

Earnings by Quarter for Windtree Therapeutics (OTCMKTS:WINT)

Windtree Therapeutics (OTCMKTS WINT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/21/2017Q2 2017($0.99)($0.76)$0.40 million$1.15 millionViewN/AView Earnings Details
5/15/2017Q1 2017($1.37)$0.22 millionViewN/AView Earnings Details
8/10/2016Q2($1.64)($1.29)$0.08 million$0.11 millionViewN/AView Earnings Details
5/12/2016Q116($1.58)($1.70)$0.08 millionViewListenView Earnings Details
3/24/2016Q4($0.70)($1.26)$0.07 million$0.66 millionViewListenView Earnings Details
8/10/2015Q215($0.13)($0.13)$0.45 million$0.08 millionViewListenView Earnings Details
3/16/2015Q414($0.14)($0.12)$0.54 million$1.18 millionViewN/AView Earnings Details
11/6/2014($0.15)($0.13)$0.50 million$0.53 millionViewN/AView Earnings Details
8/5/2014Q2 14($0.15)($0.12)$0.26 million$1.09 millionViewN/AView Earnings Details
5/8/2014Q114($0.13)($0.14)$2.69 million$0.03 millionViewN/AView Earnings Details
3/13/2014Q413($0.16)($0.16)$0.36 million$0.07 millionViewN/AView Earnings Details
11/12/2013Q3($0.20)($0.22)$0.11 millionViewListenView Earnings Details
8/8/2013Q2 2013($0.28)($0.18)$10.00 million$0.18 millionViewN/AView Earnings Details
11/8/2012Q312($0.23)($0.31)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Windtree Therapeutics (OTCMKTS:WINT) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Windtree Therapeutics (OTCMKTS:WINT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Windtree Therapeutics (OTCMKTS WINT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.80%
Institutional Ownership Percentage: 0.33%
Insider Trades by Quarter for Windtree Therapeutics (OTCMKTS:WINT)
Institutional Ownership by Quarter for Windtree Therapeutics (OTCMKTS:WINT)

Windtree Therapeutics (OTCMKTS WINT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/28/2016Craig FraserInsiderBuy7,500$2.05$15,375.00View SEC Filing  
2/19/2013John R LeoneDirectorBuy3,000$2.88$8,640.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Windtree Therapeutics (OTCMKTS WINT) News Headlines

Source:

SEC Filings

Windtree Therapeutics (OTCMKTS:WINT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Windtree Therapeutics (OTCMKTS:WINT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Windtree Therapeutics (OTCMKTS WINT) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.